Register  /  Login               

Mark Griffiths, Carbogen Amcis Group CEO and Paolo Armanino SVP of the Highly Potent Unit (India) – Dishman

Keywords:

e-version image

Click HERE to download the PDF

 

 

DISHMAN CARBOGEN AMCIS GROUP IS CONTINUALLY INVESTING IN THE GLOBAL PHARMACEUTICAL INDUSTRY IN ORDER TO PROVIDE PHARMACEUTICAL CUSTOMERS WITH HIGH VALUE, HIGH-QUALITY PRODUCTS AND SERVICES. CAN YOU ENTER INTO DETAILS OF THESE INVESTMENTS? WHAT IS YOUR FOCUS?

MG: We are a customer focussed enterprise and as such take great efforts to understand what our clients need today and what they might need in the future to enable them to bring new drugs to patients. As such we are constantly introducing new capabilities to facilitate our clients, such as Highly potent capability, ozonolysis, irradiation capability etc. Essentially our business is the business of our clients!

 

WHAT IS THE PORTFOLIO OF SERVICES YOU OFFER?

MG: ... ...




About us



tks | publisher, event organiser,
media agency

Viale Brianza, 22
20127 - Milano - Italy

info@teknoscienze.com
Tel. +39 02 26809375